Last Friday, the FDA -- after rejecting them once -- finally approved Novo's two new Insulins, Tresiba and Ryzodeg. (See article for details.) Do you feel comfortable in recommending either to your patients? Follow the link to respond.

A new clinical study suggests that diets high in protein, independent of caloric intake, improve metabolic health.

The #1 app to bring food transparency and effectively access reliable information such as the nutritive value for a variety of foodstuffs. Follow link for more information.

64-year female presents to your office for her 3-month follow-up. She has previously been diagnosed with mild diastolic heart failure, secondary to hypertension. She currently takes an ace-inhibitor and a diuretic with good control of her heart failure symptoms and hypertension. At her last visit, she had a FPG 118 mg/dl. In a subsequent conversation with her, you discussed how she has developed prediabetes and suggested lifestyle modifications. Since her last visit, she has taken up very gentle walking four times/week and has changed her diet to a more healthful one. Despite these positive changes, this visit's labs return an A1C 7.8%; her remaining labs are within normal limits. Which one of the following antihyperglycemic medication classes would you choose to initiate treatment? A. Sulfonylureas B. Biguanides C. Insulin D. Thiazolidinediones For the complete question and answer, just follow the link!

Lack of resuspension alters PK/PD and result in poor glycemic controls.

Fiber found to reduce absorption rate of glucose in rats...

Asian-Americans develop type 2 diabetes at lower BMI than the general population...

The link between obesity and diabetes possibly uncovered...

Patients on PPAR-gamma agonists advised to find suitable physical activity...

Risk found to be neutral, but duration of diabetes and increased risk of bone fracture need further study...